Loading...
•
Mar 31, 2024
UFP Technologies Q1 2024 Earnings Report
UFP Technologies reported record Q1 results with increased net sales and income compared to the previous year.
Key Takeaways
UFP Technologies reported a strong first quarter with a 7.4% organic sales growth in both MedTech and Advanced Components businesses. Operating income and net income increased by 24% and 30%, respectively driven by growth in robotic surgery and infection prevention revenue.
Net sales for Q1 2024 were $105.0 million, compared to $97.8 million in Q1 2023.
Net income for Q1 2024 was $12.7 million, or $1.64 per diluted share, compared to $9.7 million, or $1.27 per diluted share in Q1 2023.
Organic sales growth of 7.4% was achieved in both the MedTech and Advanced Components businesses.
Expansion in the Dominican Republic is largely complete, contributing to enhanced gross margins.
Revenue by Segment
Forward Guidance
UFP Technologies is optimistic about its future due to continued growth, progress on strategic initiatives, and a strong balance sheet.
Positive Outlook
- Exciting pipeline of active acquisition opportunities, with multiple projects already in the due diligence phase.
- Continued growth in core business segments.
- Progress on strategic initiatives.
- Strong balance sheet with only around $34 million in debt.
- Mexico operation sales grew 47% over the prior year.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...